Kista, Sweden

Per Johansson

This inventor holds 2 USPTO granted patents. Top assignee: Biovitrum Ab. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Per Johansson. Retrieved from https://idiyas.com/inventor/per-johansson-o3lee3n8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Per Johansson: Innovator in Biomedicine

Introduction

Per Johansson is a notable inventor based in Kista, Sweden. He has made significant contributions to the field of biomedicine, particularly in the area of obesity and diabetes treatment. With a total of 2 patents, Johansson's work is recognized for its potential impact on medical science.

Latest Patents

Johansson's latest patents focus on promoter sequences related to the human Site-1 Protease. The first patent describes an isolated human Site-1 Protease promoter region. This invention also includes screening methods for agents that decrease the expression of Site-1 protease, which could be useful in treating medical conditions associated with obesity and diabetes. The second patent mirrors the first, emphasizing the importance of this research in developing therapeutic strategies.

Career Highlights

Per Johansson is associated with Biovitrum AB, a company known for its innovative approaches in biotechnology. His work at Biovitrum has allowed him to explore and develop groundbreaking solutions in the medical field.

Collaborations

Johansson has collaborated with notable colleagues such as Jonas Ekblom and Margareta Forsgren. Their combined expertise has contributed to the advancement of research in their respective fields.

Conclusion

Per Johansson's innovative work in biomedicine, particularly regarding obesity and diabetes, showcases his commitment to improving health outcomes through scientific research. His patents reflect a promising future for therapeutic advancements in these critical areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…